Trials / Completed
CompletedNCT00698178
Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Lotung Poh-Ai Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Gastroesophageal reflux disease (GERD) is a common and important disorder. Previous studies have demonstrated the association of obesity with GERD, and now obesity is regarded as a risk factor for GERD. Moreover, body mass index (BMI), an indicator of general obesity, correlates with severity of symptoms and degree of erosive esophagitis. Waist circumference, an indicator of abdominal obesity, has stronger correlation with intra-abdominal pressure and low-grade inflammatory state when compared with BMI. Nevertheless the association of waist circumference with severity of GERD has not been studied. The primary aim of this study is to compare BMI with waist circumference for their independent association with severity of GERD. The secondary aim is to evaluate independent risk factors of severity of GERD.
Detailed description
This is a cross-section observational study. Outpatients presenting with acid reflux or heart burn are interviewed with standardized questionnaire to quantify severity of symptoms. The eligible patients undergo upper endoscopy to diagnose erosive esophagitis and further classify the degree of erosions according to Los-Angels classification. Enrolled patients receive anthropometric measurements to record body weight, body height and waist circumference on the day of enrollment. Two outcomes are studied: the severity of GERD symptoms and the Los-Angels Classification of erosive esophagitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anthropometric measurements | All patients undergo anthropometric measurements to record body weight, body height and waist circumference on the day of enrollment |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-07-01
- Completion
- 2009-08-01
- First posted
- 2008-06-17
- Last updated
- 2010-10-19
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00698178. Inclusion in this directory is not an endorsement.